Little information is available concerning the neurotoxicity of ioversol injected in animals. The effects of ioversol and other contrast media as well as vehicle control on the blood-brain barrier (BBB) were examined by injection into the left carotid artery of Mongolian gerbils 1 min prior to the i.v. injection of [8-14C]dopamine. The animals were sacrificed 1 min after the i.v. injection to prepare the frontal brain sections following the stereotaxic atlas. No uptake of the labeled substance was observed when the vehicle control and ioversol were used, suggesting that exposure to ioversol does not damage the BBB. Both meglumine sodium amidotrizoate and iohexol caused damage to the BBB, as shown in the cerebral cortex, brain stem, and hippocampus sections in the left semisphere. Iopaidol induced a much less but significant effect. Our results suggest that ioversol is an useful contrast medium.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1248/bpb.17.257 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Data Mining and Analysis for Iodinated Contrast Media Adverse Event Signals Based on the Food and Drug Administration Adverse Event Reporting System Database.
Clin Ther
January 2025
Pharmacy department, Affiliated Banan Hospital of Chongqing Medical University, Chongqing, China.
Article Synopsis
- This study analyzed the FDA Adverse Event Reporting System (FAERS) database to investigate negative reactions associated with iodinated contrast media (ICM) over nearly two decades (2004-2023).
- It focused on five types of ICMs, assessing 11 million reports to identify the nature and strength of adverse events linked to these drugs using various statistical methods.
- Findings indicated significant adverse drug reactions primarily related to respiratory and immune disorders, with specific concerns for throat irritation among females linked to ioversol and iopromide.
Comparative Safety Profiles and Usage Patterns of Iodinated Contrast Media in Medical Imaging.
Diagnostics (Basel)
November 2024
Department of Radiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 07345, Republic of Korea.
Objectives: This study aimed to analyze the usage patterns and hypersensitivity reaction (HSR) profiles of six nonionic iodinated contrast media (ICMs) used in computed tomography (CT) to enhance patient safety and inform evidence-based contrast agent selection.
Methods: We retrospectively reviewed 248,209 CT scans obtained between January 2020 and December 2022. Six ICMs (iomeprol, iohexol, ioversol, iopromide, iodixanol, and iobitridol) were compared on the basis of their usage rates, HSR incidence, and severity.
Comparison of Image Quality and Safety Profile between Ethiodol and Ioversol Contrast Medium for Hysterosalpingography: A Meta-Analysis.
Tohoku J Exp Med
October 2024
Department of Radiology, Wushan County People's Hospital of Chongqing.
Ultrasound-guided ventral approach to the brachial plexus block in barred owls (Strix varia): a cadaveric study.
Vet Anaesth Analg
October 2024
Department of Veterinary Clinical Sciences, College of Veterinary Medicine, University of Minnesota, MN, USA.
Objective: To develop an ultrasound (US)-guided ventral approach to the brachial plexus (BP) and evaluate nerve anatomy and staining in barred owl cadavers.
Study Design: Prospective, cadaveric study.
Animals: Eleven adult male and female barred owl cadavers with a body mass of 0.
Impact of different concentration iodinated contrast media on pain and comfort in abdominal computed tomography.
Eur J Radiol
October 2024
Department of Radiology, Peking University Cancer Hospital and Institute, Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Beijing 100142, China.
Objectives: To investigate whether high concentration iodinated contrast media (CM), compared with low concentration CM, could reduce pain and discomfort levels in patients who had level II and III venous conditions.
Methods: This prospective, single-center study enrolled patients who had level II and III venous conditions and underwent abdominal contrast-enhanced CT scan between July 2021 and February 2022. The venous condition to establish peripheral venous access for CM injection was graded using the Intravenous Access Scoring system, of which level II and III indicated poor venous condition and difficult venous access.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!